Jones Ventures INTL Acquisition1
JONE · NASDAQ
About JONE
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Jul 14, 2026
- Sector
- N/A
- Industry
- N/A
JONE key statistics
- Market cap
- 281.90M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 47.28K
- Volume
- 42.94K
- Open price
- $9.81
- High today
- $9.82
- Low today
- $9.81
- 52 Week high
- $10.00
- 52 Week low
- $9.78
Jones Ventures INTL Acquisition1 (JONE) at a glance
As of Nov 2, 2026, Jones Ventures INTL Acquisition1 (JONE) shares are priced at $9.82, giving the company a market cap of 281.90M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $9.81 and $9.82. The current price is 0.1% above the day's low and 0.0% below its high.
Volume so far is 42.94K shares, in line with the average of 47.28K shares a day.
Over the past year Jones Ventures INTL Acquisition1 has ranged from $9.78 to $10.00, and now sits 18% of the way up that range.
Most active stocks
Highest trading volume today
- INLFINLIF$0.2899+56.70%
- RBNERobin Energy$0.151+8.95%
- GMZPGemz$0.0001−50.00%
- INTCIntel$59.97−8.80%
- INOInovio Pharmaceuticals$1.90+215.31%
- XXII22nd Century Group$0.0741+6.47%
- NVDGraniteShares ETF Trust$4.54+2.60%
- TMGITransglobal Management Group$0.0001−33.33%
- BDMDBaird Medical Investment Holdings$0.138−13.97%
- SOXLDirexion Shares ETF Trust$68.17−11.52%
- RDARRaadr$0.0002+0.00%
- EARIEntertainment Arts Research$0.0002+0.00%
Newly listed
Companies that went public in the past six weeks
- GBCGEORGIA BANKING$37.28−2.87%
- BHAIUBHAV Acquisition Corp II$10.00+0.15%
- SCQCUSPACCircle Acquisition$9.97−0.15%
- LYCALycia Therapeutics$27.18+2.95%
- DAVIDAVION HEALTHCARE$1.49−11.31%
- TCXBTCGX Acquisition Corp. II$10.10−0.39%
- CTYCITY THERAPEUTICS$20.88+0.82%
- IAMIambic Therapeutics$12.96−3.54%
- AMROAmaero$5.72+2.88%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.16−0.10%
- TRXBTRex Bio$13.64−0.73%
- RTSNRetension Pharmaceuticals$11.30−0.53%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.